| Title |
Page ID |
Namespace |
Size (bytes) |
Last change
|
| [[Blood–brain barrier|]] |
84936 |
0 |
54393 |
20190117105105
|
| [[Intravenous therapy|]] |
178769 |
0 |
40184 |
20190108160032
|
| [[Route of administration|]] |
334816 |
0 |
29025 |
20190115070859
|
| [[Subcutaneous injection|]] |
334820 |
0 |
4046 |
20190107095300
|
| [[Intramuscular injection|]] |
334821 |
0 |
8579 |
20190107095300
|
| [[Therapeutic index|]] |
334955 |
0 |
20399 |
20181231145536
|
| [[Injection (medicine)|]] |
665909 |
0 |
14929 |
20190111154901
|
| [[Cytochrome P450|]] |
709137 |
0 |
49994 |
20190117100127
|
| [[Therapeutic drug monitoring|]] |
739219 |
0 |
4914 |
20181217063807
|
| [[Bioavailability|]] |
769021 |
0 |
22147 |
20181204133035
|
| [[ADME|]] |
826690 |
0 |
6152 |
20181208191145
|
| [[Bioequivalence|]] |
998103 |
0 |
14201 |
20181202155139
|
| [[Prodrug|]] |
1017427 |
0 |
12119 |
20190105155457
|
| [[Cimetidine|]] |
1018112 |
0 |
50117 |
20190107221409
|
| [[CYP3A4|]] |
1024582 |
0 |
48387 |
20190117100132
|
| [[CYP2D6|]] |
1024815 |
0 |
29535 |
20190117100132
|
| [[CYP2E1|]] |
1024830 |
0 |
23203 |
20190117100132
|
| [[Polypharmacy|]] |
1099391 |
0 |
25926 |
20190103145504
|
| [[Drug interaction|]] |
1099396 |
0 |
44028 |
20190115190456
|
| [[Toxicokinetics|]] |
1112289 |
0 |
3616 |
20181124175936
|
| [[Drug metabolism|]] |
1173475 |
0 |
28070 |
20190117062839
|
| [[Toxication|]] |
1173482 |
0 |
8800 |
20181117220121
|
| [[First pass effect|]] |
1173539 |
0 |
4796 |
20181231150249
|
| [[Volume of distribution|]] |
1272743 |
0 |
7013 |
20181109232927
|
| [[Aromatase|]] |
1415048 |
0 |
27049 |
20190117100137
|
| [[Physiologically based pharmacokinetic modelling|]] |
1566437 |
0 |
25277 |
20181117220123
|
| [[Effective half-life|]] |
1728145 |
0 |
2594 |
20181010124401
|
| [[Drug action|]] |
2070741 |
0 |
5915 |
20181221103905
|
| [[Polymersome|]] |
2218269 |
0 |
6943 |
20180929133937
|
| [[Clearance (pharmacology)|]] |
2402393 |
0 |
13244 |
20190114112233
|
| [[Haber's rule|]] |
2463278 |
0 |
3182 |
20181004165113
|
| [[CYP2A6|]] |
2516515 |
0 |
11644 |
20190117100155
|
| [[Enteric coating|]] |
2910903 |
0 |
9850 |
20190113221504
|
| [[Trough level|]] |
2962530 |
0 |
1936 |
20181010124518
|
| [[Biological half-life|]] |
3206099 |
0 |
13872 |
20181117220129
|
| [[Loading dose|]] |
3291372 |
0 |
3766 |
20181109232927
|
| [[Distribution (pharmacology)|]] |
3665681 |
0 |
9706 |
20181127032709
|
| [[Microdosing|]] |
3845621 |
0 |
5774 |
20190114190444
|
| [[Ethnopsychopharmacology|]] |
4189719 |
0 |
7015 |
20181014221721
|
| [[P450-containing systems|]] |
4277840 |
0 |
10609 |
20190117100221
|
| [[CYP1A2|]] |
4320289 |
0 |
22911 |
20190117100221
|
| [[Epoxyeicosatrienoic acid|]] |
4367754 |
0 |
49168 |
20190115133053
|
| [[Grapefruit–drug interactions|]] |
4387617 |
0 |
55511 |
20181231234649
|
| [[Initial volume of distribution|]] |
4629153 |
0 |
1687 |
20181221105004
|
| [[CYP2C9|]] |
4779665 |
0 |
27521 |
20190117100228
|
| [[CYP2C19|]] |
4779761 |
0 |
23851 |
20190117100228
|
| [[CYP2C8|]] |
4779795 |
0 |
13153 |
20190117100228
|
| [[Cytochrome P450, family 1, member A1|]] |
5119921 |
0 |
14296 |
20190117100234
|
| [[Enzyme induction and inhibition|]] |
5245810 |
0 |
2570 |
20180929134736
|
| [[Context-sensitive half-life|]] |
5507641 |
0 |
5320 |
20181222034944
|
| [[CYP1B1|]] |
5900320 |
0 |
8431 |
20190117100250
|
| [[CYP17A1|]] |
5914077 |
0 |
19201 |
20190117100250
|
| [[Plasma protein binding|]] |
6025636 |
0 |
8443 |
20190114190623
|
| [[Binding potential|]] |
6075099 |
0 |
5734 |
20180929134930
|
| [[Absorption (pharmacology)|]] |
6194872 |
0 |
8109 |
20181227105718
|
| [[Targeted drug delivery|]] |
6470547 |
0 |
29101 |
20181117220136
|
| [[CYP27A1|]] |
6700732 |
0 |
10770 |
20190117100419
|
| [[Cholesterol side-chain cleavage enzyme|]] |
6796314 |
0 |
22369 |
20190117100422
|
| [[Dosage form|]] |
7481381 |
0 |
5887 |
20190112170427
|
| [[Osmotic-controlled release oral delivery system|]] |
8031252 |
0 |
12541 |
20190107095300
|
| [[21-Hydroxylase|]] |
8852888 |
0 |
17070 |
20190117100519
|
| [[Modified-release dosage|]] |
9360334 |
0 |
24525 |
20190115023910
|
| [[NONMEM|]] |
9365585 |
0 |
2303 |
20181023170705
|
| [[Pharmacokinetics|]] |
9674107 |
0 |
39961 |
20190111155232
|
| [[Cytochrome P450 reductase|]] |
9736045 |
0 |
18592 |
20190117100553
|
| [[Pharmacometrics|]] |
10162690 |
0 |
5168 |
20190108081442
|
| [[Dose (biochemistry)|]] |
10449471 |
0 |
19391 |
20181117220144
|
| [[CYP2B6|]] |
10456228 |
0 |
15614 |
20190117100638
|
| [[CYP3A7|]] |
10680502 |
0 |
2223 |
20190117100650
|
| [[Lanosterol 14 alpha-demethylase|]] |
10906045 |
0 |
15122 |
20190117100705
|
| [[PEGylation|]] |
10931846 |
0 |
17579 |
20181125212916
|
| [[Bolus (medicine)|]] |
12238660 |
0 |
4028 |
20190107095300
|
| [[Dissolution testing|]] |
12458572 |
0 |
9824 |
20180727142641
|
| [[Flip-flop kinetics|]] |
13589014 |
0 |
1806 |
20170925222345
|
| [[Dose dumping|]] |
14007566 |
0 |
1873 |
20190105155735
|
| [[Cholesterol 24-hydroxylase|]] |
14045189 |
0 |
18819 |
20190117100815
|
| [[IdMOC|]] |
14350461 |
0 |
3830 |
20190116030740
|
| [[Ion trapping|]] |
14440094 |
0 |
4782 |
20181030184709
|
| [[Active metabolite|]] |
14564960 |
0 |
3539 |
20190116030743
|
| [[CYP3A|]] |
14798557 |
0 |
8481 |
20190117100835
|
| [[Table of volume of distribution for drugs|]] |
14848284 |
0 |
1952 |
20180929140604
|
| [[Compartment (pharmacokinetics)|]] |
14848805 |
0 |
1715 |
20181109232927
|
| [[Table of medication secernated in kidney|]] |
14848938 |
0 |
4653 |
20181026163436
|
| [[Skin popping|]] |
15151817 |
0 |
2523 |
20190107135449
|
| [[Magnetic marker monitoring|]] |
15342613 |
0 |
2193 |
20181010125624
|
| [[Simcyp Simulator|]] |
16157480 |
0 |
3740 |
20180929140750
|
| [[Maintenance dose|]] |
16698745 |
0 |
2530 |
20181109232927
|
| [[Free fraction|]] |
16823207 |
0 |
3223 |
20181221113956
|
| [[CYP2C9*13|]] |
18420839 |
0 |
7711 |
20190117101022
|
| [[Rate of infusion|]] |
18872320 |
0 |
1105 |
20181109232927
|
| [[Elimination rate constant|]] |
19094964 |
0 |
3366 |
20181109232927
|
| [[Dermal patch|]] |
20016657 |
0 |
1211 |
20190116030827
|
| [[CYP2C9*3|]] |
22685256 |
0 |
1478 |
20190117101216
|
| [[Chemotactic drug-targeting|]] |
22787622 |
0 |
1696 |
20181221115703
|
| [[Cmin|]] |
22982241 |
0 |
1264 |
20181222035059
|
| [[Cmax (pharmacology)|]] |
23184916 |
0 |
3490 |
20190114174555
|
| [[Area under the curve (pharmacokinetics)|]] |
23518221 |
0 |
3802 |
20181109005510
|
| [[Bioanalysis|]] |
23604382 |
0 |
6026 |
20180929142056
|
| [[Dihydromethysticin|]] |
24225451 |
0 |
4389 |
20181223230630
|
| [[Plateau principle|]] |
24608545 |
0 |
22889 |
20180522075742
|
| [[Epsilon-Viniferin|]] |
24650277 |
0 |
7034 |
20181215042312
|
| [[Onset of action|]] |
24697544 |
0 |
1906 |
20181222035104
|
| [[Intradermal injection|]] |
25284347 |
0 |
3397 |
20181024105058
|
| [[Proadifen|]] |
25296374 |
0 |
3252 |
20181214171239
|
| [[Amentoflavone|]] |
26370272 |
0 |
6224 |
20190110031351
|
| [[PK/PD models|]] |
26390451 |
0 |
5349 |
20181124062011
|
| [[Oculomucocutaneous syndrome|]] |
28104937 |
0 |
1640 |
20190106161817
|
| [[Lipophilic efficiency|]] |
28819446 |
0 |
5742 |
20181119052101
|
| [[Parallel artificial membrane permeability assay|]] |
28893371 |
0 |
5083 |
20181117220204
|
| [[Cobicistat|]] |
29240014 |
0 |
10662 |
20190111100418
|
| [[Cooperstown cocktail|]] |
31190054 |
0 |
2748 |
20181221121832
|
| [[PottersWheel|]] |
31376465 |
0 |
8275 |
20190115122951
|
| [[Rhapontigenin|]] |
35281330 |
0 |
3510 |
20181214171240
|
| [[Blood–gas partition coefficient|]] |
35737600 |
0 |
4185 |
20181205223518
|
| [[Liberation (pharmacology)|]] |
39490884 |
0 |
4011 |
20181222035144
|
| [[Elimination (pharmacology)|]] |
39490943 |
0 |
7081 |
20190116031029
|
| [[20-Hydroxyeicosatetraenoic acid|]] |
47836404 |
0 |
79670 |
20190115133053
|
| [[Epoxydocosapentaenoic acid|]] |
49599350 |
0 |
15811 |
20181016222046
|
| [[Epoxyeicosatetraenoic acid|]] |
49854427 |
0 |
23013 |
20180929145841
|
| [[Cytochrome P450 omega hydroxylase|]] |
50110441 |
0 |
12100 |
20180929145902
|
| [[Residence time|]] |
50390340 |
0 |
32156 |
20190110022349
|
| [[Variable volume pharmacokinetic models|]] |
51553756 |
0 |
4901 |
20180929150119
|
| [[Intracerebroventricular injection|]] |
53597220 |
0 |
2784 |
20181117220233
|
| [[Physical pharmacy|]] |
57989671 |
0 |
2480 |
20190108191157
|
| [[Drug accumulation ratio|]] |
57998655 |
0 |
315 |
20181010132647
|
| [[Cmean (pharmacology)|]] |
58105226 |
0 |
584 |
20181010132652
|
